Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/183023Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Martín Pérez, Miguel | - |
| dc.contributor.author | Urdiroz Urricelqui, Uxue | - |
| dc.contributor.author | Bigas, Claudia | - |
| dc.contributor.author | Aznar Benitah, Salvador | - |
| dc.date.accessioned | 2022-02-09T16:46:12Z | - |
| dc.date.available | 2022-11-20T06:10:29Z | - |
| dc.date.issued | 2021-11-20 | - |
| dc.identifier.issn | 2452-3100 | - |
| dc.identifier.uri | http://hdl.handle.net/2445/183023 | - |
| dc.description.abstract | Alterations in lipid metabolism are being increasingly implicated in the initiation, aggressiveness, and progression to metastasis of cancers. Recent advances have shown that high levels of fat availability and altered lipid metabolism can promote the metastatic process by i) providing energy for cancer cells, thereby supporting invasion and colonization, ii) promoting their survival by enhancing antioxidative, antiapoptotic mechanisms, and therapy resistance, and iii) inhibiting the immune surveillance from detecting/removing tumor cells. These findings are especially disturbing given the alarmingly high fat intake within our modern diet. However, the reprogramming of fat metabolism exhibited by cancer cells and intratumor immune cells promises to generate new pharmacological opportunities to treat metastasis. © 2021 Elsevier Ltd | ca |
| dc.format.extent | 20 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | ca |
| dc.publisher | Elsevier | ca |
| dc.relation.isformatof | versió postprint del document publicat a: https://doi.org/10.1016/j.coisb.2021.100401 | - |
| dc.relation.ispartof | Current Opinion In Systems Biology, 2021, vol.28, num.100401 | - |
| dc.relation.uri | https://doi.org/10.1016/j.coisb.2021.100401 | - |
| dc.rights | cc by-nc-nd (c) Elsevier, 2021 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
| dc.subject.classification | Metabolisme dels lípids | - |
| dc.subject.classification | Metàstasi | - |
| dc.subject.classification | Tractament adjuvant del càncer | - |
| dc.subject.other | Lipid metabolism | - |
| dc.subject.other | Metastasis | - |
| dc.subject.other | Adjuvant treatment of cancer | - |
| dc.title | Lipid metabolism in metastasis and therapy | ca |
| dc.type | info:eu-repo/semantics/article | ca |
| dc.type | info:eu-repo/semantics/acceptedVersion | - |
| dc.date.updated | 2022-02-09T10:13:57Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| dc.identifier.idimarina | 6543012 | - |
| Appears in Collections: | Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona)) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 12541_6543012_curropinsysbiol_martin-perez_et_al_2021.pdf | 692.19 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
